Evidence map›Paper›PMID 34401301›Full record

ArticleRespiratory medicine case reports2021

E-cigarette, or vaping, product use associated lung injury and the risks and benefits of a thorough infectious work-up.

Jessica Lilley, Shena Kravitz, Zachary Haynes, Tyler Church, Sean McKay, Andrew Mertz

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jessica LilleyUniformed Services University of the Health Sciences, Bethesda, MD, USA.
Shena KravitzTransitional Year Internship, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Zachary HaynesDivision of Internal Medicine, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Tyler ChurchDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Sean McKayDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Andrew MertzDivision of Internal Medicine, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As of February 2020, over 2800 cases of lung injury associated with vapes have been reported in all 50 states (Cullen et al., 2019) [1]. This case is about a 29-year-old female with a five-year history of vaping tetrahydrocannabinol (THC) who presented with symptoms consistent with e-cigarette, or vaping, product-use associated lung injury (EVALI). This case report is unique because this patient clinically improved on a lower dose of corticosteroids compared to other reported cases of EVALI. Additionally, this case report highlights the importance and difficulty of excluding other disease processes prior to treating patients for EVALI, particularly during the coronavirus disease 2019 (COVID-19) global pandemic.

Indexed as

CorticosteroidDiagnosis of exclusione-Cigarette, or vapingEVALIInfectionProduct-use associated lung injuryTetrahydrocannabinolTHCTreatmentVapeVaping

Identifiers

PMID34401301
PMCPMC8349039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.